Lite Strategy, Inc. also files under MEIP, MSHL; those filings are included. Filings under LITS by Goldrich Mining Co (CIK 0000059860) from Oct 2, 2003 to Jun 30, 2008 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Flynn James P | Director | Buy(P) | 25K | $0.86 | $21K |
| Feb 12, 2026 | File Justin J. | CEO, CFO and Secretary, Director | Grant(A) | 455K | — | — |
| Dec 19, 2025 | Flynn James P | Director | Buy(P) | 70K | $1.40 | $98K |
| Dec 18, 2025 | Schornstein Alexander | 10% Owner | Sell(S) | 691K | $1.37 | $946K |
| Nov 19, 2025 | Flynn James P | Director | Buy(P) | 12K | $1.88 | $23K |
| Nov 14, 2025 | Riezman Joshua | Director | Grant(A) | 10K | — | — |
| Nov 14, 2025 | Riezman Joshua | Director | Grant(A) | 55K | — | — |
| Nov 14, 2025 | Flynn James P | Director | Grant(A) | 55K | — | — |
| Nov 14, 2025 | Glover Nicholas | Director | Grant(A) | 55K | — | — |
| Nov 14, 2025 | File Justin J. | CEO, CFO and Secretary, Director | Grant(A) | 180K | — | — |
| Nov 14, 2025 | Driscoll Frederick W | Director | Grant(A) | 55K | — | — |
| Oct 3, 2025 | Lee Charles Benjamin | Director | Grant(A) | 10K | — | $0 |
| Sep 30, 2025 | Flynn James P | Director | Grant(A) | 10K | $2.54 | $25K |
| Aug 8, 2025 | Riezman Joshua | Director | Grant(A) | 10K | — | $0 |
| Jul 15, 2025 | Wood Steven D | Director | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | Flynn James P | Director | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | File Justin J. | Secretary, Acting CEO & CFO | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | Driscoll Frederick W | Director | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | Glover Nicholas | Director | Grant(A) | 20K | — | $0 |
| Jul 15, 2025 | Reynolds Thomas C | Director | Grant(A) | 20K | — | $0 |
| May 17, 2024 | Wood Steven D | Director | Grant(A) | 3K | $3.17 | $10K |
| May 16, 2024 | Flynn James P | Director | Grant(A) | 8K | $3.16 | $25K |
| Dec 18, 2023 | Flynn James P | Director | Grant(A) | 7K | — | $0 |
| Dec 18, 2023 | Wood Steven D | Director | Grant(A) | 10K | — | $0 |
| Dec 18, 2023 | Flynn James P | Director | Grant(A) | 10K | — | $0 |
| Dec 18, 2023 | Wood Steven D | Director | Grant(A) | 7K | — | $0 |
| Oct 20, 2023 | Funicular Funds, LP | 10% Owner | Option exercise(X) | 1K | — | $0 |
| Oct 20, 2023 | Funicular Funds, LP | 10% Owner | Expiration(E) | 4K | — | $0 |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Option exercise(X) | 36K | $7.00 | $251K |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Option exercise(X) | 1K | — | $0 |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Option exercise(X) | 358 | — | $0 |
| Oct 20, 2023 | Funicular Funds, LP | 10% Owner | Option exercise(X) | 121K | $7.00 | $844K |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Option exercise(X) | 143K | $7.00 | $1.0M |
| Oct 20, 2023 | Kassam Moez | 10% Owner | Expiration(E) | 7K | — | $0 |
| Oct 11, 2023 | Ma-Weaver Jacob | 10% Owner | Option exercise(X) | 300 | — | $0 |
| Oct 11, 2023 | Ma-Weaver Jacob | 10% Owner | Option exercise(X) | 30K | $7.00 | $210K |
| Oct 11, 2023 | Anson Funds Management LP | 10% Owner | Option exercise(X) | 100 | — | $0 |
| Oct 11, 2023 | Anson Funds Management LP | 10% Owner | Option exercise(X) | 400 | — | $0 |
| Oct 11, 2023 | Anson Funds Management LP | 10% Owner | Option exercise(X) | 10K | $7.00 | $70K |
| Oct 11, 2023 | Anson Funds Management LP | 10% Owner | Option exercise(X) | 40K | $7.00 | $280K |
| Sep 29, 2023 | Baltic Charles V. III | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Ghalie Richard G | Chief Medical Officer | Grant(A) | 30K | — | $0 |
| Sep 29, 2023 | Driscoll Frederick W | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Gold Daniel P PHD | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Reynolds Thomas C | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Glover Nicholas | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Howson Tamar D | Director | Grant(A) | 10K | — | $0 |
| Sep 29, 2023 | Kango Sujay | Director | Grant(A) | 10K | — | $0 |
| Sep 22, 2023 | Ma-Weaver Jacob | 10% Owner | Buy(P) | 32K | $6.85 | $219K |
| Sep 22, 2023 | Winson Bruce Ross | 10% Owner | Buy(P) | 48K | $6.85 | $329K |
| Sep 22, 2023 | Winson Bruce Ross | 10% Owner | Sell(S) | 9K | $0.15 | $1K |
| Sep 22, 2023 | Ma-Weaver Jacob | 10% Owner | Sell(S) | 6K | $0.14 | $840 |
| Sep 21, 2023 | Kassam Moez | 10% Owner | Buy(P) | 34K | $6.46 | $217K |
| Sep 21, 2023 | Ma-Weaver Jacob | 10% Owner | Buy(P) | 22K | $6.46 | $145K |
| Sep 20, 2023 | Kassam Moez | 10% Owner | Buy(P) | 120K | $6.01 | $721K |
| Sep 20, 2023 | Ma-Weaver Jacob | 10% Owner | Buy(P) | 80K | $6.01 | $481K |
| Jun 2, 2023 | Urso David M | President and CEO, Director | Grant(A) | 167K | — | $0 |
| Feb 28, 2023 | Baltic Charles V. III | Director | Buy(P) | 82K | $0.23 | $19K |
| Jul 5, 2022 | Cohen Cheryl | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Gold Daniel P PHD | Chief Executive Officer, Director | Grant(A) | 1.5M | — | $0 |
| Jul 5, 2022 | Drazba Brian G. | Chief Financial Officer | Grant(A) | 350K | — | $0 |
| Jul 5, 2022 | Reynolds Thomas C | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | White Christine Anna | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Howson Tamar D | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Urso David M | Chief Operating Officer & GC | Grant(A) | 1.1M | — | $0 |
| Jul 5, 2022 | Glover Nicholas | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Kango Sujay | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Ghalie Richard G | Chief Medical Officer | Grant(A) | 560K | — | $0 |
| Jul 5, 2022 | Ghalie Richard G | Chief Medical Officer | Tax withholding(F) | 8K | $0.54 | $4K |
| Jul 5, 2022 | Baltic Charles V. III | Director | Grant(A) | 88K | — | $0 |
| Jul 5, 2022 | Driscoll Frederick W | Director | Grant(A) | 88 | — | $0 |
| Nov 22, 2021 | Kango Sujay | Director | Grant(A) | 58K | — | $0 |
| Jul 2, 2021 | Urso David M | Chief Operating Officer & GC | Tax withholding(F) | 25K | $2.94 | $73K |
| Jul 2, 2021 | Gold Daniel P PHD | Chief Executive Officer, Director | Tax withholding(F) | 41K | $2.94 | $121K |
| Jul 1, 2021 | Urso David M | Chief Operating Officer & GC | Grant(A) | 600K | — | $0 |
| Jul 1, 2021 | Gold Daniel P PHD | Chief Executive Officer, Director | Grant(A) | 855K | — | $0 |
| Jul 1, 2021 | Howson Tamar D | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Reynolds Thomas C | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Cohen Cheryl | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Glover Nicholas | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Driscoll Frederick W | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Clemens Kevan | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Baltic Charles V. III | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2021 | Ghalie Richard G | Chief Medical Officer | Grant(A) | 320K | — | $0 |
| Jul 1, 2021 | Drazba Brian G. | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Jul 1, 2021 | White Christine Anna | Director | Grant(A) | 50K | — | $0 |
| May 25, 2021 | Gold Daniel P PHD | Chief Executive Officer, Director | Option exercise(M) | 5K | $2.52 | $13K |
| May 25, 2021 | Gold Daniel P PHD | Chief Executive Officer, Director | Option exercise(M) | 5K | — | $0 |
| May 3, 2021 | Ghalie Richard G | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Feb 23, 2021 | Driscoll Frederick W | Director | Sell(S) | 25K | $4.03 | $101K |
| Jul 23, 2020 | Gold Daniel P PHD | Chief Executive Officer, Director | Option exercise(M) | 12K | $1.57 | $19K |
| Jul 23, 2020 | Gold Daniel P PHD | Chief Executive Officer, Director | Option exercise(M) | 12K | — | $0 |
| Jul 2, 2020 | Urso David M | Chief Operating Officer & GC | Grant(A) | 525K | — | $0 |
| Jul 2, 2020 | Urso David M | Chief Operating Officer & GC | Grant(A) | 50K | — | $0 |
| Jul 2, 2020 | Mass Robert D. | Chief Medical Officer | Grant(A) | 230K | — | $0 |
| Jul 2, 2020 | Howson Tamar D | Director | Grant(A) | 50K | — | $0 |
| Jul 2, 2020 | Drazba Brian G. | Chief Financial Officer | Grant(A) | 230K | — | $0 |
| Jul 2, 2020 | Clemens Kevan | Director | Grant(A) | 50K | — | $0 |
| Jul 2, 2020 | Baltic Charles V. III | Director | Grant(A) | 50K | — | $0 |
| Jul 2, 2020 | Gold Daniel P PHD | Chief Executive Officer, Director | Grant(A) | 680K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Lite Strategy, Inc., SEC CIK 0001262104. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under LITS and shows every filing by that issuer (also filed as MEIP, MSHL). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for LITS